Selected publications:
Markaki I, Ntetsika T, Sorjonen K, Svenningsson P; BioPark Study Group. Euglycemia Indicates Favorable Motor Outcome in Parkinson’s Disease. Mov Disord. 2021 Feb 26. doi: 10.1002/mds.28545.
Full publications:
- Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial
- The noradrenergic subtype of Parkinson disease: from animal models to clinical practice
- Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
- On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI-MS Imaging
- Aberrant somatic calcium channel function in cNurr1 and LRRK2-G2019S mice
- [18F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
- [11 C]PBB3 binding in Aβ(-) or Aβ(+) corticobasal syndrome
- β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk
- Longitudinal DAT changes measured with [18F]FE-PE2I PET in patients with Parkinson's disease; a validation study
- Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome
- Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
- Impaired migratory phenotype of CD4+ T cells in Parkinson's disease
- Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP- 363856
- Impaired Aversive Memory Formation in GPR37L1KO Mice
- Single-cell transcriptomics reveals correct developmental dynamics and high-quality midbrain cell types by improved hESC differentiation